Cerebral Palsy
Understanding Cerebral Palsy & Emerging Regenerative Approaches
Cerebral palsy (CP) is a group of lifelong conditions that affect movement, muscle tone and posture. It is caused by injury to, or differences in, the developing brain before, during or shortly after birth.
Alongside therapy-based care, researchers are investigating whether umbilical cord blood cells and mesenchymal stem cells (MSCs) can support brain repair in children with CP. Evidence remains early and preliminary.
Why Cerebral Palsy Treatment Matters
Cerebral palsy is the most common physical disability in childhood. Its effects range from mild differences in movement to significant physical disability, and many children also experience pain, epilepsy, or communication and learning difficulties.
Current care focuses on early intervention, physiotherapy, occupational and speech therapy, medicines for spasticity and, in some cases, surgery. These approaches help children build skills and independence.
Because the underlying brain injury cannot currently be repaired, researchers are exploring whether regenerative approaches could support the developing brain's own recovery.
Understanding Cerebral Palsy & Regenerative Medicine
The young brain has a strong capacity to adapt and form new connections, especially in the early years. Researchers are investigating whether cell-based therapies could enhance this natural plasticity.
Most studies have used umbilical cord blood cells or MSCs, given mainly by infusion into a vein. These cells are thought to act by releasing signals that reduce inflammation and support brain repair, rather than becoming new brain cells.
Some small randomised trials have suggested modest short-term improvements in motor function, particularly with adequate cell doses. Evidence remains early and preliminary, and larger trials with longer follow-up are needed.
At a Glance
- Lifelong conditions affecting movement and posture
- Caused by injury to, or differences in, the developing brain
- Most common physical disability in childhood
- Therapy-based care remains the foundation
- Cord blood cells and MSCs are being studied
- Some small trials suggest modest motor improvements
- Evidence remains early and preliminary
- Specialist paediatric assessment is essential
How it works
How Regenerative Medicine Is Being Studied for Alzheimer's Disease
Researchers are investigating whether cells given early in life can create a more supportive environment for the developing brain.
Studies assess safety, gross motor function and changes in brain connectivity over the following months.
01
Reducing Brain Inflammation
Cord blood cells and MSCs are being studied for their ability to calm inflammation linked to brain injury.
02
Supporting Neuroplasticity
Researchers are examining whether cell-based therapies can enhance the developing brain's natural ability to form new connections.
03
Protecting Brain Tissue
Studies are exploring whether cell-derived signals can help protect brain cells and the white matter that connects them.
05
Measuring Motor Function
Clinical studies use standardised scales to assess whether changes in movement are meaningful and lasting.
04
Investigating Dose & Timing
Trials are studying how cell dose and the child's age at treatment affect any measurable response.
06
Building Clinical Evidence
Larger, well-controlled trials with longer follow-up are needed to confirm safety and benefit.
Visual flow
Cerebral Palsy
Injury to the developing brain affects movement
Specialist Assessment
Paediatric review of diagnosis, imaging and therapy
Personalised Approach
Evidence-led discussion alongside ongoing therapy
Who May Consider Cerebral Palsy Treatment?
Every child with cerebral palsy is different. Decisions depend on the type and severity of CP, age, overall health and current therapy.
People who may seek specialist information about cerebral palsy and emerging regenerative approaches include:
Families of Children With Cerebral Palsy
Parents and carers who want reliable information about current care and emerging research.
Adults Living With Cerebral Palsy
Individuals who want to understand how regenerative research may or may not apply to them.
Families Following Cord Blood Research
People interested in what clinical trials of cord blood and MSCs have shown so far.
Is Regenerative Treatment Right for You?
A specialist paediatric evaluation should always come before considering any emerging or investigational therapy.
The Journey of Cerebral Palsy Research
From Early Intervention to Cell-Based Research
Understanding Brain Injury
Research clarified how injury to the developing brain leads to the movement patterns seen in CP.
Early Intervention
Studies showed that early, intensive therapy helps children make the most of the brain's plasticity.
Cord Blood Trials
Clinical trials began testing umbilical cord blood cells in children with cerebral palsy.
Ongoing Research
Researchers are now studying doses, cell types and timing to determine who may benefit.
Ready to Learn More?
Cerebral palsy research continues to evolve, but early findings are not proof of benefit. Understanding what has been studied can help families make informed decisions alongside their child's care team.
Hear From the People Advancing Cerebral Palsy Research
Professor Interviews
Hear a leading cerebral palsy researcher give an update on the state of stem cell science.
Medical Podcasts
Listen to a clinician-researcher discuss how different types of early brain injury shape development in CP.
Patient Perspectives
Gap: no suitable non-clinic patient video found. Hide this card or replace it with a family story from the Cerebral Palsy Alliance channel.
Continue the Conversation
Cerebral palsy research is progressing, but cell therapy is not yet an established treatment. Understanding the evidence, safety considerations and regulatory status of a treatment is an important part of making an informed decision.
Questions patients ask before applying
Can stem cells cure cerebral palsy?
No. There is no cure for cerebral palsy. Research is investigating whether cell-based therapies can support brain repair, but evidence remains early.
What types of cells are being studied?
Most studies have used umbilical cord blood cells or mesenchymal stem cells, given mainly by infusion into a vein.
What have clinical trials shown?
Some small randomised trials have suggested modest short-term improvements in motor function, particularly with adequate cell doses. Larger trials with longer follow-up are needed.
Does age matter?
Research suggests the developing brain is most adaptable in early childhood, and many trials have focused on young children. A specialist can explain how this applies to an individual.
Is stem cell therapy approved for cerebral palsy?
Approval depends on the specific therapy and country. Families should always verify the regulatory status of any proposed treatment.
Should therapy continue?
Yes. Physiotherapy, occupational therapy, speech therapy and medical care remain central and should not be stopped because an emerging approach is being explored.